Current Opinion in Allergy and Clinical Immunology

Papers
(The TQCC of Current Opinion in Allergy and Clinical Immunology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Primary immune regulatory disorders: a growing universe of immune dysregulation52
Global immunoglobulin supply: steaming towards the iceberg?47
Clinical phenotypes of adult atopic dermatitis and related therapies32
Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia30
Vaccine allergy: evidence to consider for COVID-19 vaccines29
Tolerance mechanisms in allergen immunotherapy29
Rubella virus-associated chronic inflammation in primary immunodeficiency diseases24
The role of atopy in asthma development and persistence24
Omalizumab as monotherapy for food allergy24
Can patients with oral allergy syndrome be at risk of anaphylaxis?23
COVID-19 and X-linked agammaglobulinemia (XLA) – insights from a monogenic antibody deficiency23
Vernal keratoconjunctivitis and keratoconus23
Artificial stone silicosis22
Childhood asthma in the new omics era: challenges and perspectives22
Atopic dermatitis and its relation to food allergy22
Small-airway dysfunction in paediatric asthma21
Omalizumab as an adjuvant in food allergen immunotherapy21
Mechanism and diagnosis of protein contact dermatitis20
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host–environmental interactions20
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity20
Update on omalizumab in allergen immunotherapy18
The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseases18
Choice of biologics in asthma endotypes17
Antibody therapy for COVID-1917
COVID-19 in complex common variable immunodeficiency patients affected by lung diseases16
Current state of occupational latex allergy16
Microbiota in non-IgE-mediated food allergy16
Cleaners and airway diseases15
Biological agents for severe asthma: the evolution of the at-home self-injection approach15
Epithelial-to-mesenchymal transition in neutrophilic chronic rhinosinusitis15
Gastroesophageal reflux and asthma: when, how, and why14
Allergic conjunctivitis in children: current understanding and future perspectives14
Adverse reactions to vancomycin and cross-reactivity with other antibiotics14
Role of clinical history in beta-lactam hypersensitivity14
Cow's milk allergy14
Omalizumab and other biologics in drug desensitization14
Autologous serum eye drops for ocular surface disorders14
Vitamin D: can the sun stop the atopic epidemic?14
Application of exhaled nitric oxide (FeNO) in pediatric asthma14
Inflammatory endotypes of CRSwNP and responses to COVID-1913
Artificial intelligence and the hunt for immunological disorders13
Eosinophilic esophagitis as a complication of food oral immunotherapy12
New guidance on the regulation of allergen products: key aspects and outcomes12
Novel vaccines for allergen-specific immunotherapy12
Fractional exhaled nitric oxide and asthma treatment adherence11
Occupational exposures and idiopathic pulmonary fibrosis11
Epidemiology of anaphylaxis11
Adult vernal keratoconjunctivitis11
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 201911
Eosinophilic gastroenteritis: epidemiology, diagnosis, and treatment11
The impact of obesity on immune function in pediatric asthma11
Food allergy: how expensive are they?11
COVID-19 and autoimmune diseases: is there a connection?10
Air pollution and childhood asthma10
Probiotics in food allergy10
The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis10
Host–microbiome intestinal interactions during early life: considerations for atopy and asthma development10
Unique features of non-IgE-mediated gastrointestinal food allergy during infancy in Japan10
Precision medicine in cow's milk allergy10
Urticaria and the gut9
Prevention of baker's asthma9
Allergen immunotherapy and biologics in respiratory allergy: friends or foes?9
Genetics and epigenetics of allergy9
Predicting the course of asthma from childhood until early adulthood9
Alpha1-antitrypsin deficiency and asthma9
Grading the severity of anaphylaxis9
Biologics for eosinophilic granulomatosis with polyangiitis8
Food protein-induced enterocolitis syndrome: epidemiology and comorbidities8
Neutrophilic inflammation in chronic rhinosinusitis8
The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents8
Immediate hypersensitivity reactions to steroids and steroid containing medications8
Occupational aspects of irritable larynx syndrome8
Angioedema without urticaria: novel findings which must be measured in clinical setting8
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy8
Exploring the origin and regulatory role of mast cells in asthma8
An update on the epigenetics of asthma8
Severe asthma: what is new in the new millennium8
Basophil activation test in food allergy: is it ready for real-time?8
Oral mite anaphylaxis: who, when, and how?8
Pediatric asthma in developing countries: challenges and future directions8
Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis8
Chronic rhinosinusitis: phenotypes and endotypes8
Non-IgE-mediated food allergy during infancy8
Biologicals for the prevention of anaphylaxis7
Biologics and severe asthma in children7
Emerging approaches in the diagnosis and therapy in shellfish allergy7
Replacing defective thymus function7
Addressing the impact of ethnicity on asthma care7
Molecular diagnosis usefulness for idiopathic anaphylaxis7
Exhaled nitric oxide in asthma: from diagnosis to management7
Natural history and long-term follow-up of Hymenoptera allergy7
Allergen immunotherapy for pediatric asthma: current evidence and knowledge gaps7
Anaphylactic reactions to biological drugs7
Classifying cephalosporins: from generation to cross-reactivity7
Is asthma a risk factor for coronavirus disease-2019 worse outcomes? The answer is no, but …7
Drug allergy management in the elderly7
Cellular interactions in aspirin-exacerbated respiratory disease7
Epinephrine in anaphylaxis: too little, too late7
0.080060005187988